Verona Pharma Plc (DELISTED) (VRNA:DL)
106.91
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
Verona Pharma EPS Diluted (Quarterly): 0.1327 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| AstraZeneca PLC | 0.8065 |
| GSK Plc | 1.323 |
| Haleon Plc | -- |
| Adaptimmune Therapeutics Plc | -0.1163 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.06M |
| Revenue (Quarterly) | 104.36M |
| Total Expenses (Quarterly) | 92.30M |
| Enterprise Value | 9.054B |
| Gross Profit Margin (Quarterly) | 95.10% |
| Profit Margin (Quarterly) | 11.56% |
| Earnings Yield | -0.96% |
| Normalized Earnings Yield | -0.9294 |